NEW YORK (GenomeWeb News) — Panagene has licensed PNA monomers from the Copenhagen Inventor Group that allows Panagene to synthesize, make, and sell peptide nucleic acids, the company said Tuesday.
 
The South Korean company adds this license agreement to a previous one with CIG for patents for PNA custom synthesis.
 
Panagene estimated that it is currently around 5 percent of the DNA/RNA synthesis market and said the new license will enable it to increase this share “significantly.”

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Five researchers are to share this year's Albany Medical Center Prize for their work on the CRISPR/Cas9 gene-editing tool, the AP reports.

Stat News reports on how white supremacists cope with surprising genetic ancestry testing results.

In Genome Research this week: sex-biased gene expression evolution in malaria mosquitos, method to find ancient selective sweeps, and more.

Iceland has nearly eliminated Down syndrome from its population, CBS News reports.